Pulmonary delivery of antibiotics has attracted much attention in recent years but formulation and aerosolization of these agents has remained to be a challenge since many drugs are susceptible to chemical and/or physical degradation.
The research and development of skin drug delivery systems for topical and transdermal routes concentrates on delivery of both pharmaceutical and cosmetic active ingredients.
The Molecular recognition materials research has been successful in the development of related applications of the molecular recognition processes involving a range of molecular imprinting techniques.
The transmucosal routes of drug delivery offer distinct advantages over peroral administration for systemic drug delivery such as possible bypass of the first pass effect and avoidance of presystemic elimination within the GI tract.
These bioinks will be particularly used for 3D bioprinting to obtain printed networks that mimic biological environment to benefit the effectiveness in drug delivery investigation.
It is very much challenging to characterize microbiome-drug interaction within this dynamic ecosystem to fulfill the gap of knowledge on pharmacology/pharmacokinetics of drug delivery systems.